Omnicell | OMCL - Net Income


Omnicell reported $5.64M in Net Income for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 2.15B
Cash and Equivalent USD 399M
Cost of Sales USD 162.88M
Current Assets USD 844.78M
Current Liabilities USD 594.39M
Debt USD 341.26M
EBIT USD 8.3M
EBITDA USD 38.38M
Employees 3.67K
EPS Earnings Per Share USD 0.45
Equity Capital and Reserves USD 1.26B
Gross Profit on Sales USD 127.68M
Interest Expense on Debt USD 1.08M
Loan Capital USD 166.99M
Market Capitalization USD 1.47B
Net Income USD 5.64M
Operating Expenses USD 282.26M
Operating Profit USD 8.3M
Ordinary Share Capital USD 46.84M
PE Price to Earnings USD 45.76
Pre-Tax Profit USD 10.45M
Sales Revenues USD 290.56M
Selling and Administration Expenses USD 97.99M
Stock USD 105.78M
Trade Creditors USD 62.41M
Trade Debtors USD 232.68M

Net Income Change Date
Becton, Dickinson and Co. USD 574M 266M Jun/2025
Cardinal Health USD 239M 267M Jun/2025
Cerillion plc 8.06M 2.05M Mar/2024
IQVIA Holdings USD 266M 17M Jun/2025
McKesson USD 784M 476M Jun/2025
Omnicell USD 5.64M 12.66M Jun/2025
Stanley Black & Decker USD 101.9M 11.5M Jun/2025
Steris USD 177.4M 31.73M Jun/2025
Veeva Systems USD 200.31M 27.88M Jul/2025